| The role of platelets in inflammation MR Thomas, RF Storey Thrombosis and haemostasis 114 (09), 449-458, 2015 | 611 | 2015 |
| Microvesicles in vascular homeostasis and diseases VC Ridger, CM Boulanger, A Angelillo-Scherrer, L Badimon, ... Thrombosis and haemostasis 117 (07), 1296-1316, 2017 | 248 | 2017 |
| Understanding infection-induced thrombosis: lessons learned from animal models N Beristain-Covarrubias, M Perez-Toledo, MR Thomas, IR Henderson, ... Frontiers in immunology 10, 473478, 2019 | 164 | 2019 |
| Novel risk markers and risk assessments for cardiovascular disease MR Thomas, GYH Lip Circulation research 120 (1), 133-149, 2017 | 157 | 2017 |
| Platelet inhibition with ticagrelor 60 mg versus 90 mg twice daily in the PEGASUS-TIMI 54 trial RF Storey, DJ Angiolillo, MP Bonaca, MR Thomas, HM Judge, F Rollini, ... Journal of the American College of Cardiology 67 (10), 1145-1154, 2016 | 138 | 2016 |
| Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human ModelSignificance MR Thomas, SN Outteridge, RA Ajjan, F Phoenix, GK Sangha, ... Arteriosclerosis, thrombosis, and vascular biology 35 (12), 2562-2570, 2015 | 138 | 2015 |
| Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation W Chua, Y Purmah, VR Cardoso, GV Gkoutos, SP Tull, G Neculau, ... European heart journal 40 (16), 1268-1276, 2019 | 125 | 2019 |
| Effect of P2Y12 inhibitors on inflammation and immunity MR Thomas, RF Storey Thrombosis and haemostasis 114 (09), 490-497, 2015 | 105 | 2015 |
| Effect of hypoglycemia on inflammatory responses and the response to low-dose endotoxemia in humans A Iqbal, LR Prince, P Novodvorsky, A Bernjak, MR Thomas, L Birch, ... The Journal of Clinical Endocrinology & Metabolism 104 (4), 1187-1199, 2019 | 85 | 2019 |
| Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease RC Orme, WAE Parker, MR Thomas, HM Judge, K Baster, W Sumaya, ... Circulation 138 (13), 1290-1300, 2018 | 83 | 2018 |
| Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI PLR Nicolson, CE Hughes, S Watson, SH Nock, AT Hardy, CN Watson, ... haematologica 103 (12), 2097, 2018 | 69 | 2018 |
| Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction MR Thomas, AC Morton, R Hossain, B Chen, L Luo, NNBM Shahari, ... Thrombosis and haemostasis 116 (07), 96-102, 2016 | 65 | 2016 |
| A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors PLR Nicolson, JD Welsh, A Chauhan, MR Thomas, ML Kahn, SP Watson Platelets 31 (5), 685-690, 2020 | 42 | 2020 |
| Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases MH Harbi, CW Smith, PLR Nicolson, SP Watson, MR Thomas Platelets 32 (1), 29-41, 2021 | 41 | 2021 |
| Antiplatelet therapy in acute coronary syndromes EL Grove, M Würtz, MR Thomas, SD Kristensen Expert Opinion on Pharmacotherapy 16 (14), 2133-2147, 2015 | 41 | 2015 |
| Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive … BA Fisher, T Veenith, D Slade, C Gaskell, M Rowland, T Whitehouse, ... The Lancet Respiratory Medicine 10 (3), 255-266, 2022 | 40 | 2022 |
| Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib N Cooper, I Altomare, MR Thomas, PLR Nicolson, SP Watson, ... Therapeutic Advances in Hematology 12, 20406207211010875, 2021 | 38 | 2021 |
| Cangrelor versus ticagrelor in patients treated with primary percutaneous coronary intervention: impact on platelet activity, myocardial microvascular function and infarct size … S Ubaid, TJ Ford, C Berry, HM Murray, B Wrigley, N Khan, MR Thomas, ... Thrombosis and Haemostasis 119 (07), 1171-1181, 2019 | 38 | 2019 |
| Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis KF Alsharif, MR Thomas, HM Judge, H Khan, LR Prince, I Sabroe, ... Vascular Pharmacology 71, 201-207, 2015 | 36 | 2015 |
| A platelet P-selectin test predicts adverse cardiovascular events in patients with acute coronary syndromes treated with aspirin and clopidogrel MR Thomas, YD Wijeyeratne, JA May, A Johnson, S Heptinstall, SC Fox Platelets 25 (8), 612-618, 2014 | 34 | 2014 |
